DKCM
CELU icon

Davidson Kempner Capital Management’s Celularity CELU Stock Holding History

Davidson Kempner Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-89,199
Closed -$9M – 579
2021
Q1 		$9M Buy
89,199
+16,759
+23% +$1.72M 0.09% 157
2020
Q4 		$7.97M Buy
+72,440
New +$7.7M 0.09% 156

Other funds holding CELU

WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Davidson Kempner Capital Management's CELU Position: Q2 2021 in Review

Davidson Kempner Capital Management sold out of Celularity (CELU) in Q2 2021, closing a stake of 89,199 shares — an estimated $9M sold.

Davidson Kempner Capital Management first reported a position in CELU in Q4 2020 and held it in 2 quarters. The position peaked at $9M in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • Davidson Kempner Capital Management reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 89,199 Celularity shares in Q2 2021, an estimated $9M.
  • Davidson Kempner Capital Management first reported a position in Celularity in Q4 2020 and held it in 2 quarters.
  • Davidson Kempner Capital Management's Celularity position peaked at $9M in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.